| Literature DB >> 27547026 |
Guanqun Liao1, Shunqian Wen1, Xueyi Xie1, Qing Wu1.
Abstract
BACKGROUND AND OBJECTIVES: Laparoscopic cholecystectomy (LC) using surgical electrocautery is considered to be the gold standard procedure for the treatment of uncomplicated cholecystitis and cholelithiasis. The objective of the current study was to evaluate the effectiveness and safety of the Harmonic scalpel, an advanced laparoscopic technique associated with less thermal damage in LC, when compared to electrocautery.Entities:
Keywords: Electrocautery; Harmonic scalpel; Laparoscopic cholecystectomy
Mesh:
Year: 2016 PMID: 27547026 PMCID: PMC4978547 DOI: 10.4293/JSLS.2016.00037
Source DB: PubMed Journal: JSLS ISSN: 1086-8089 Impact factor: 2.172
Baseline Characteristics of Per-Protocol Set
| Experimental Group (n = 117) | Control Group (n = 81) | ||
|---|---|---|---|
| Age, years, mean ± SD | 42.2 ± 10.4 | 43.4 ± 11.1 | 0.913 |
| Sex, male/female | 51/66 | 40/41 | 0.421 |
| BMI, kg/m2, mean ± SD | 24.6 ± 3.1 | 25.0 ± 3.6 | 0.275 |
| Gallbladder disease, n (%) | 103 (88.0) | 73 (90.1) | 0.348 |
| Polypoid lesion | 11 (9.4) | 8 (9.9) | |
| Others | 3 (2.6) | 0 (0.0) | |
| Concomitant medical conditions, n (%) | |||
| Cardiac insufficiency | 1 (0.8) | 0 (0.0) | 1.000 |
| Hypertension | 5 (4.3) | 2 (2.5) | 0.776 |
| Liver cirrhosis | 1 (0.8) | 2 (2.5) | 0.747 |
| Diabetes mellitus | 2 (1.7) | 0 (0.0) | 0.514 |
| Depression | 0 (0.0) | 1 (1.2) | 0.409 |
n = 198.
Operative and Postoperative Data
| Experimental Group (n = 117) | Control Group (n = 81) | ||
|---|---|---|---|
| Operative time, min, mean ± SD | 54.9 ± 13.1 | 51.7 ± 9.6 | 0.079 |
| Blood loss, mL, mean ± SD | 14.2 ± 10.6 | 13.7 ± 9.1 | 0.367 |
| Conversion to laparotomy, n (%) | 1 (0.8) | 0 (0.0) | 0.404 |
| Postoperative complications, n (%) | |||
| Surgical site infection | 0 (0.0) | 1 (1.2) | 0.228 |
| Postoperative pneumonia | 1 (0.8) | 0 (0.0) | 0.404 |
| Bile leak | 1 (0.8) | 0 (0.0) | 0.404 |
| CBD injury | 1 | 0 | 0.404 |
| PHS, days, mean ± SD | 3.0 ± 0.4 | 2.9 ± 0.4 | 0.315 |
n = 198.
Postoperative Pain and Nausea/Vomiting
| Experimental Group (n = 117) | Control Group (n = 81) | ||
|---|---|---|---|
| Postoperative pain, point, mean ± SD | 54.9 ± 13.1 | 51.7 ± 9.6 | 0.079 |
| Day 0.5 | 2.4 ± 0.8 | 2.3 ± 0.8 | 0.695 |
| Day 1 | 1.7 ± 0.7 | 1.6 ± 0.8 | 0.020 |
| Day 2 | 1.7 ± 0.6 | 1.5 ± 0.7 | 0.015 |
| Day 7 | 0.1 ± 0.3 | 0.1 ± 0.4 | 0.066 |
| Dose of additional analgesic, mg, mean ± SD | |||
| Day 1 | |||
| NSAIDs | 0.3 ± 0.7 | 0.3 ± 0.6 | 0.484 |
| Tramadol | 0.2 ± 0.4 | 0.2 ± 0.4 | 0.317 |
| Day 2 | |||
| NSAIDs | 0.03 ± 0.18 | 0.04 ± 0.19 | 0.832 |
| Postoperative nausea/vomiting, point, mean ± SD | |||
| Day 1 | 2.7 ± 1.2 | 2.7 ± 1.2 | 0.915 |
| Day 2 | 2.0 ± 1.2 | 1.9 ± 1.2 | 0.473 |
| Day 3 | 1.4 ± 0.8 | 1.2 ± 0.7 | 0.527 |
n = 198.